欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
714	Doxorubicin Hydrochloride	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2003-111 - Rev 07	2025/07/28	Valid		Chemical	2025/12/03	Minor revision\|Accepted - CEP remains valid\|03/12/2025; Notification\|CEP granted\|28/07/2025; Minor revision\|CEP granted\|29/05/2024; Notification\|Accepted - CEP remains valid\|23/01/2023; Notification\|CEP granted\|20/12/2021; Minor revision\|Accepted - CEP remains valid\|27/05/2021
1559	Risperidone	ICROM S.R.L. Concorezzo IT	100022464;100031145	CEP 2023-293 - Rev 00	2025/07/28	Valid	28/07/2030	Chemical	2025/07/28	New application\|CEP granted\|28/07/2025
1524	Gliclazide	ANUH PHARMA LTD. Mumbai IN	100021566;100030259	CEP 2021-398 - Rev 02	2025/07/28	Valid	11/08/2028	Chemical	2026/02/09	Notification\|Accepted - CEP remains valid\|09/02/2026; Minor revision\|CEP granted\|28/07/2025; Minor revision\|CEP granted\|20/12/2023; New application\|CEP granted\|11/08/2023
1653	Potassium clavulanate, diluted, with microcrystalline Cellulose in the ratio 7:3	FERMIC, S.A. DE C.V. Mexico City MX	100017232;100026028	CEP 2009-358 - Rev 01	2025/07/28	Valid		Chemical	2025/07/28	Notification\|CEP granted\|28/07/2025
574	Cholecalciferol concentrate (powder form), 100 000 IU/g, with all-rac-α-tocopherol	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2019-003 - Rev 01	2025/07/28	Valid		Chemical and TSE	2025/07/28	Renewal\|CEP granted\|28/07/2025; Minor revision\|Accepted - CEP remains valid\|30/11/2023
333	Heparin sodium	SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. Shenzhen City CN	100012154;100018639	CEP 2006-059 - Rev 20	2025/07/28	Valid		Chemical	2026/01/21	Monograph revision\|Accepted - CEP remains valid\|21/01/2026; Major revision\|CEP granted\|28/07/2025; Minor revision\|CEP granted\|27/08/2024; Monograph revision\|CEP granted\|14/05/2024; Administrative procedure\|CEP granted\|04/10/2023; Major revision\|CEP granted\|26/09/2023; Minor revision\|CEP granted\|21/02/2023; Major revision\|CEP granted\|31/03/2021; Minor revision\|CEP granted\|28/10/2020; Minor revision\|CEP granted\|21/04/2020
319	Colistimethate sodium	LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Fuzhou CN	100020920;100029633	CEP 2018-085 - Rev 06	2025/07/28	Valid		Chemical	2025/07/28	Minor revision\|CEP granted\|28/07/2025; Renewal\|CEP granted\|15/01/2025; Monograph revision\|Accepted - CEP remains valid\|24/03/2023; Administrative procedure\|CEP granted\|06/12/2022; Minor revision\|CEP granted\|28/11/2022; Minor revision\|CEP granted\|11/01/2022; Administrative procedure\|CEP granted\|05/05/2020
2992	Lacosamide, Crystalline form-1	MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN	100014794;100023345	CEP 2018-060 - Rev 05	2025/07/28	Valid		Chemical	2025/07/28	Minor revision\|CEP granted\|28/07/2025; Renewal\|CEP granted\|19/07/2024; Notification\|CEP granted\|25/10/2023; Minor revision\|CEP granted\|14/02/2023; Minor revision\|Accepted - CEP remains valid\|02/02/2022; Minor revision\|CEP granted\|25/09/2020
2930	Valganciclovir hydrochloride, Crystalline form	MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village IN	100013041;100021615	CEP 2023-285 - Rev 00	2025/07/28	Valid	28/07/2030	Chemical	2025/07/28	New application\|CEP granted\|28/07/2025
2887	Raltegravir potassium, Form III	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	CEP 2023-193 - Rev 00	2025/07/28	Valid	28/07/2030	Chemical	2025/07/28	New application\|CEP granted\|28/07/2025
40	Magnesium oxide, light	SCORA Caffiers FR	100017757;100026517	CEP 2024-141 - Rev 00	2025/07/28	Valid	28/07/2030	Chemical	2025/07/28	New application\|CEP granted\|28/07/2025
.	Newborn Bovine Calf Serum	GLOBAL LIFE SCIENCES SOLUTIONS NEW ZEALAND Tauranga NZ	100052523;100092494	CEP 2001-190 - Rev 07	2025/07/25	Valid		TSE	2025/07/25	Notification\|CEP granted\|25/07/2025; Major revision\|CEP granted\|28/03/2023; Major revision\|CEP granted\|22/02/2023; Notification\|Accepted - CEP remains valid\|03/03/2022; Notification\|CEP granted\|05/06/2020
1339	Levocarnitine	NORTHEAST PHARMACEUTICAL GROUP CO. LTD Shenyang CN	100021339;100054155	CEP 2022-068 - Rev 01	2025/07/25	Valid	19/01/2029	Chemical	2025/07/25	Minor revision\|CEP granted\|25/07/2025; New application\|CEP granted\|19/01/2024
2362	Rifaximin, Alpha Form	OLON S.P.A. Rodano IT	100012085;100019537	CEP 2019-125 - Rev 04	2025/07/25	Valid		Chemical	2025/07/25	Renewal\|CEP granted\|25/07/2025; Minor revision\|Accepted - CEP remains valid\|06/09/2024; Minor revision\|Accepted - CEP remains valid\|05/02/2024; Administrative procedure\|CEP granted\|05/07/2021; Minor revision\|CEP granted\|21/06/2021; Minor revision\|CEP granted\|18/12/2020
2593	Docetaxel, Process-IIb	INTAS PHARMACEUTICALS LIMITED Ahmedabad IN	100011529;100023432	CEP 2020-155 - Rev 02	2025/07/25	Valid		Chemical	2025/07/25	Renewal\|CEP granted\|25/07/2025; Minor revision\|CEP granted\|26/09/2024; New application\|CEP granted\|18/09/2020
319	Colistimethate sodium	LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Lianyungang CN	100019457;100028232	CEP 2015-189 - Rev 01	2025/07/25	Valid		Chemical	2025/07/25	Minor revision\|CEP granted\|25/07/2025; Minor revision\|Accepted - CEP remains valid\|20/08/2024; Major revision\|Accepted - CEP remains valid\|01/09/2023; Monograph revision\|Accepted - CEP remains valid\|16/05/2023; Renewal\|CEP granted\|10/12/2021
2258	Olanzapine, Micronised (Form-II), RX Code	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2025-203 - Rev 00	2025/07/25	Valid	25/07/2030	Chemical	2025/07/25	New application\|CEP granted\|25/07/2025
968	Aciclovir, Micronised and non-micronised	AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN	100046306;100076393	CEP 2020-013 - Rev 03	2025/07/25	Valid		Chemical	2025/09/29	Renewal\|Accepted - CEP remains valid\|29/09/2025; Minor revision\|CEP granted\|25/07/2025; Minor revision\|CEP granted\|26/03/2025; Minor revision\|CEP granted\|25/10/2022; New application\|CEP granted\|04/02/2021
2362	Rifaximin, Process-II	OPTIMUS DRUGS PRIVATE LIMITED Hyderabad IN	100020646;100092226	CEP 2025-071 - Rev 00	2025/07/25	Valid	25/07/2030	Chemical	2025/07/25	New application\|CEP granted\|25/07/2025
2778	Sitagliptin phosphate monohydrate, Process III	ZHEJIANG JINGSHENG PHARMACEUTICAL CO., LTD. Taizhou City CN	100048181;100079705	CEP 2025-109 - Rev 00	2025/07/25	Valid	25/07/2030	Chemical	2025/07/25	New application\|CEP granted\|25/07/2025

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-